BeOne Medicines (ONC) Treasury Shares (2015 - 2018)
BeOne Medicines (ONC) reported Treasury Shares of $14.1 million for Q4 2018, up 859.71% year-over-year from $1.5 million in Q4 2017, and up 2571.4% on a QoQ basis from $527904.0 in Q2 2018.
BeOne Medicines (ONC) has 4 years of Treasury Shares data on file, last reported at $14.1 million in Q4 2018.
- Quarterly Treasury Shares rose 859.71% year-over-year to $14.1 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $14.1 million (up 859.71% YoY) and the FY2018 annual result came in at $14.1 million, up 1649.14% from the prior year.
- Treasury Shares climbed to $14.1 million in Q4 2018 per ONC's latest filing, from $527904.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $14.1 million in Q4 2018 and bottomed at $44445.0 in Q4 2015.
- The 4-year median for Treasury Shares is $1.2 million (2017), against an average of $3.2 million.
- The widest annual swing landed in 2016, when Treasury Shares jumped 2318.72%; it then jumped 36.69% in 2017.
- Tracing ONC's Treasury Shares over 4 years: stood at $44445.0 in 2015, then jumped by 2318.72% to $1.1 million in 2016, then jumped by 36.69% to $1.5 million in 2017, then jumped by 859.71% to $14.1 million in 2018.
- Per Business Quant, the three latest ONC Treasury Shares figures stand at $14.1 million (Q4 2018), $527904.0 (Q2 2018), and $4.1 million (Q1 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 700,000.00 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 34.70 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | BeOne Medicines | - | - | 1.35 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 14.10 Mn |
| Dec 31, 2018 | 14.10 Mn |
| Jun 30, 2018 | 527,904.00 |
| Jun 30, 2018 | 527,904.00 |
| Mar 31, 2018 | 4.12 Mn |
| Mar 31, 2018 | 4.12 Mn |
| Dec 31, 2017 | 1.47 Mn |
| Dec 31, 2017 | 1.47 Mn |
| Sep 30, 2017 | 1.21 Mn |
| Sep 30, 2017 | 1.21 Mn |
| Dec 31, 2016 | 1.08 Mn |
| Dec 31, 2016 | 1.08 Mn |
| Dec 31, 2015 | 44,445.00 |
| Dec 31, 2015 | 44,445.00 |